Standard BioTools Inc. (LAB)
NASDAQ: LAB
· Real-Time Price · USD
1.09
0.06 (5.83%)
At close: May 28, 2025, 3:59 PM
1.10
0.46%
After-hours: May 28, 2025, 07:37 PM EDT
Standard BioTools Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|
| Collaboration and Other Revenue Revenue | 4.73M | 41.74M | 46.79M | 57.88M | 99.94M | 45.41M | 48.16M |
| Collaboration and Other Revenue Revenue Growth | -88.67% | -10.80% | -19.16% | -42.09% | +120.08% | -5.70% | n/a |
| Consumables Revenue | 60.06M | 37.46M | 25.66M | 42.5M | 22.58M | 50M | 45.49M |
| Consumables Revenue Growth | +60.35% | +45.96% | -39.61% | +88.22% | -54.85% | +9.92% | n/a |
| Instruments Revenue | 28.5M | 105.18M | 96.17M | 100.38M | n/a | 95.42M | 93.65M |
| Instruments Revenue Growth | -72.90% | +9.37% | -4.19% | n/a | n/a | +1.89% | n/a |
| Product And Service Revenue | 169.7M | 79.2M | 72.45M | 25.92M | n/a | 21.28M | 19.31M |
| Product And Service Revenue Growth | +114.27% | +9.31% | +179.56% | n/a | n/a | +10.16% | n/a |
| Product Revenue | 88.57M | 25.98M | 23.71M | n/a | n/a | n/a | n/a |
| Product Revenue Growth | +240.91% | +9.56% | n/a | n/a | n/a | n/a | n/a |
| Service Revenue | 81.13M | n/a | n/a | n/a | n/a | n/a | n/a |
| Service Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 93.46M | 46.2M | 43.98M | 63.88M | 74.59M | 47.02M | 51.17M | 20M | 18.48M | 10.93M | 12.88M | 6.56M |
| Americas Revenue Growth | +102.32% | +5.03% | -31.15% | -14.36% | +58.64% | -8.12% | +155.80% | +8.26% | +69.14% | -15.17% | +96.19% | n/a |
| Asia Pacific Revenue | 28.65M | 23.94M | 20.83M | 23.98M | 25.78M | 30.2M | 25.18M | n/a | n/a | n/a | n/a | n/a |
| Asia Pacific Revenue Growth | +19.66% | +14.94% | -13.14% | -6.98% | -14.64% | +19.97% | n/a | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue | 52.32M | 36.2M | 33.14M | 42.72M | 37.78M | 40.02M | 36.62M | n/a | n/a | n/a | n/a | n/a |
| Emea Revenue Growth | +44.52% | +9.25% | -22.44% | +13.09% | -5.62% | +9.30% | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 38.71M | 37.59M | 34.4M | 37.67M | 46.94M | 21.35M | 22.29M | 22.6M | 22.31M | 23.9M | 29.6M | 30.38M | 30.88M | 22.96M | 24.07M | 24.25M | 27.61M | 31.93M | 22.66M | 20.62M | 22.7M | 18.79M | 20.73M | 22.13M | 22.82M | 21.97M | 20.02M | 18.99M | 18.8M | 15.86M | 20.1M | 20.98M | 22.58M | 22.77M | 21.12M | 23.84M | 25.48M | 22.09M | 19.56M | 21.22M | 20.09M |
| Selling, General, and Administrative Revenue Growth | +2.98% | +9.26% | -8.68% | -19.75% | +119.83% | -4.21% | -1.36% | +1.31% | -6.67% | -19.24% | -2.59% | -1.59% | +34.47% | -4.62% | -0.73% | -12.17% | -13.55% | +40.96% | +9.89% | -9.16% | +20.78% | -9.35% | -6.35% | -3.02% | +3.88% | +9.75% | +5.44% | +0.97% | +18.55% | -21.09% | -4.16% | -7.09% | -0.85% | +7.79% | -11.42% | -6.40% | +15.35% | +12.92% | -7.84% | +5.61% | n/a |
| Research and Development Revenue | 11.33M | 14.05M | 13.16M | 19.22M | 15.98M | 6.91M | 6.37M | 6.18M | 6.41M | 8.38M | 8.65M | 12.61M | 8.87M | 8.54M | 9.21M | 9.44M | 10.75M | 11.19M | 8.13M | 8.45M | 8.7M | 8.28M | 7.13M | 7.87M | 8.37M | 7.96M | 7.43M | 7.39M | 7.26M | 7.16M | 7.68M | 7.46M | 8.52M | 8.77M | 9.25M | 9.98M | 10.41M | 9.74M | 9.44M | 10.09M | 9.99M |
| Research and Development Revenue Growth | -19.39% | +6.82% | -31.56% | +20.29% | +131.29% | +8.46% | +3.01% | -3.51% | -23.49% | -3.16% | -31.38% | +42.20% | +3.79% | -7.25% | -2.46% | -12.20% | -3.87% | +37.62% | -3.79% | -2.89% | +5.09% | +16.18% | -9.41% | -6.06% | +5.20% | +7.11% | +0.60% | +1.79% | +1.37% | -6.83% | +2.98% | -12.47% | -2.84% | -5.18% | -7.28% | -4.17% | +6.90% | +3.13% | -6.40% | +1.00% | n/a |